Oxford's Hill says its vaccine won't be available in U.S. until mid-2021 if FDA waits for trial end - Reuters

3:18pm PST - December 9th, 2020    nbc - Reuters

Jenner Institute Director Adrian Hill, who oversees the Oxford-AstraZeneca COVID-19 vaccine research and development, told NBC News that if the U.S. Food and Drug Administration waits for the end of their vaccine trial, the vaccine would not be available in t…